Featured Content |VIEW MORE
Advancing Pediatric Neuroscience: 2025 Innovation Report
The 2025 Innovation Report showcases a selection of the transformative initiatives undertaken over the past year. From pioneering clinical programs and cutting-edge research to novel therapeutic interventions, our multidisciplinary teams ...
Enhancing Precision in Pediatric Neurosurgery: Advanced Robotics Integration with LITT
Phoenix Children’s continues to advance minimally invasive neurosurgical techniques with the integration of advanced robotics into Laser Interstitial Thermal Therapy (LITT) procedures
Spotlight on Neuropsychology: An Integrated Approach to Pediatric Brain Health
Dr. Ashley Whitaker, Board-Certified Pediatric Neuropsychologist and Division Chief of Neuropsychology at Phoenix Children’s, leads a team that plays a vital role in the multidisciplinary care of children with neurological and medical complexities.
First Awake Brain Surgery at Phoenix Children’s
Dr. Jason Hauptman performed Phoenix Children’s first ever Awake Craniotomy. Watch as Dr. Hauptman performs this procedure and discusses how it enables surgeons to operate more precisely and safely.
Barrow Neurological Institute at Phoenix Children's 2024 Innovation Report
The 2024 Innovation Report highlights some of the transformative work accomplished over the past year. From groundbreaking clinical programs to cutting-edge research and novel therapeutic approaches, our multidisciplinary teams have worked ...
Cerebral Vasculopathy in Neurofibromatosis Type 1: An Under-Recognized Problem?
Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 gene, which encodes neurofibromin, a GTPase-activating protein (GAP)-related domain that negatively regulates the Ras/mitogen-activated protein ...